UPDATE: Credit Suisse Reiterates On Biogen Idec On Gilenya PPMS Risk

By: via Benzinga
In a report published Wednesday, Credit Suisse analyst Ravi Mehrotra reiterated an Outperform rating on Biogen Idec Inc (NASDAQ: BIIB), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.